Ładuje się......
Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options
Background: Gaucher disease is a rare lysosomal storage disease resulting from a deficiency or reduced activity in the acid β-glucocosidase enzyme. Only 1 treatment option was available for 15 years, but several new treatment options have come to market since 2003. Objective: The article will detail...
Zapisane w:
| Wydane w: | Hosp Pharm |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Thomas Land Publishers, Inc.
2016
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4981103/ https://ncbi.nlm.nih.gov/pubmed/27559188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5107-553 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|